Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
06/2012
06/20/2012CN102503860A Synthetic method of 1, 3-two substituted ureas and carbamate
06/20/2012CN101972669B Nucleoside preparation technology by using solvent-free melting method and catalyst used thereby
06/20/2012CN101555212B Synthesized micromolecule compound capable of conveying bioactivator and application thereof
06/20/2012CN101516892B Process for preparing n-alkyl naltrexone halides
06/20/2012CN101250208B L-nucleic acid derivative and processes for the synthesis thereof
06/19/2012US8202858 Vasopressin V1a antagonists
06/19/2012US8202854 Heterocyclic aspartyl protease inhibitors
06/19/2012CA2607151C Hiv integrase inhibitors
06/19/2012CA2504448C Transcription factor modulating compounds and methods of use thereof
06/14/2012WO2012078915A1 Macrocyclic inhibitors of flaviviridae viruses
06/14/2012WO2012078777A1 Bicyclic compounds as pim inhibitors
06/14/2012WO2012076942A1 4-aza-2, 3-didehydropodophyllotoxin compounds and process for the preparation thereof
06/14/2012US20120149718 Amido Compounds
06/14/2012US20120149698 Nouvel compounds
06/14/2012US20120149685 Composition and method for the treatment of tauopathies
06/14/2012US20120149676 Novel compounds
06/14/2012CA2819824A1 Macrocyclic inhibitors of flaviviridae viruses
06/14/2012CA2819373A1 Bicyclic compounds as pim inhibitors
06/13/2012EP2463290A1 Thienooxazepine derivative
06/13/2012EP2462147A1 Conformationally constrained, fully synthetic macrocyclic compounds
06/13/2012EP2462142A1 Metabotropic glutamate receptor modulators
06/13/2012EP2461869A1 Novel bicyclic urea compounds
06/13/2012CN1997642B 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
06/13/2012CN1898212B Analogs of benzoquinone-containing ansamycins for the treatment of cancer
06/13/2012CN102498116A Substituted dihydro benzocycloalkyloxymethyl oxazolopyrimidinones, preparation and use thereof
06/13/2012CN102491985A Synthesis method for 6-amino-2,2-dimethyl-2H-pyridino-[3,2-b] [1,4] oxazine-3(4H)-ketone
06/13/2012CN101622258B Bicyclic oxomorpholine derivative
06/13/2012CN101611038B 2-quinolinone and 2-quinoxalinone- derivatives and their use as antibacterial agents
06/13/2012CN101415419B Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators
06/13/2012CN101014598B Aminocyclohexanes as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
06/12/2012US8198435 Crystal form of N-benzoyl-staurosporine
06/12/2012CA2663965C Pyrazolopyrimidine derivative and use thereof as an anticancer agent
06/07/2012WO2012075383A2 Bromodomain inhibitors and uses thereof
06/07/2012WO2012075048A2 Hybrid cyclic libraries and screens thereof
06/07/2012WO2012074761A1 Oxazolo [5, 4 -b] pyridin- 5 -yl compounds and their use for the treatment of cancer
06/07/2012WO2012074135A1 Pyrimidine compound and use for pest control thereof
06/07/2012US20120142915 Cyclopropyl mida boronate
06/07/2012US20120142724 OXAZOLO[5-4-b]PYRIDIN-5-YL COMPOUNDS
06/07/2012US20120142722 Conjugates of cytotoxic drugs
06/07/2012US20120142647 Novel Compounds as Respiratory Stimulants for Treatment of Breathing Control Disorders or Diseases
06/07/2012US20120142635 Oxazolidinone-quinolone hybrid antibiotics
06/07/2012CA2819822A1 Oxazolo [5,4-b] pyridin-5-yl compounds and their use for the treatment of cancer
06/07/2012CA2819501A1 Hybrid cyclic libraries and screens thereof
06/07/2012CA2818187A1 Bromodomain inhibitors and uses thereof
06/06/2012EP2460805A1 Fused imidazole derivative having ttk inhibitory action
06/06/2012EP2459572A2 Spirocyclic amide derivatives
06/06/2012EP2459571A1 Nitroimidazooxazines and their uses in anti-tubercular therapy
06/06/2012EP2459570A1 Nitroimidazooxazine and nitroimidazooxazole analogues and their uses
06/06/2012EP2459560A1 Ring-annulated dihydropyrrolo[2,l-a]isoquinolines
06/06/2012EP2205599B1 Cgrp antagonists
06/06/2012EP1802635B1 Heteroatoms-containing tricyclic compounds
06/06/2012EP1560893B1 Photochromic compositions and light transmissible articles
06/06/2012CN1997651B Oxidative degradation products of atorvastatin calcium
06/06/2012CN101775026B Spiro alkaloid compound, medicinal composition comprising same and preparation method and application thereof
06/06/2012CN101568543B Macrocyclic peptides as hepatitis c virus inhibitors
06/05/2012US8193345 Purification method of lactone compounds containing unsaturated alkyl group by extraction with silver ion solution
06/05/2012US8193216 Polymorphic forms of a GABAA agonist
06/05/2012US8193214 Chymase inhibitors
06/05/2012US8193196 Causing the crystallization of the product by addition of water at a determinate temperature and for a determinate period of time, followed by a drying under controlled conditions until reaching a settled water content in the end product; bioavailability
06/05/2012CA2539349C 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
05/2012
05/31/2012WO2012071458A1 Heterocyclic inhibitors of beta - secretase for the treatment of neurodegenerative diseases
05/31/2012US20120136046 Method of treating age related disorders
05/31/2012US20120136037 Deuterium-enriched ruboxistaurin
05/31/2012US20120135981 Novel substituted triazole and imidazole derivatives as gamma secretase modulators
05/31/2012US20120135980 Gamma secretase modulators
05/31/2012US20120135961 Use of oxazolidinone-quinoline hybrid antibiotics for the treatment of anthrax and other infections
05/31/2012US20120134959 Pyrimidine compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
05/30/2012EP2457916A1 Compound for the covalent attachment of the chemiluminescent probe N-(4-Aminobutyl)-N-ethylisoluminol (ABEI) to target molecules and uses thereof
05/30/2012EP2457915A1 Chromene compound
05/30/2012EP2457913A2 Heteroaryl compounds, compositions thereof, and methods of treatment therewith
05/30/2012EP2456774A1 Fused aminodihydro-oxazine derivatives
05/30/2012CN1993367B Condensed pyrimidine derivative and xanthine oxidase inhibitor
05/30/2012CN1980939B Process for producing 1-oxacephalosporin-7alpha-methoxy-3-chloromethyl derivative
05/30/2012CN102482292A Modulators of 5-ht receptors and methods of use thereof
05/30/2012CN102482258A α-螺旋模拟物和与其相关的方法 α- helix mimetics, and methods related thereto
05/30/2012CN102482256A N-取代的环状氨基衍生物 N- substituted cyclic amino derivative
05/30/2012CN102482227A 作为γ分泌酶调节剂的取代的三唑和咪唑衍生物 As the γ-secretase modulators substituted triazole and imidazole derivatives
05/30/2012CN102477048A 喹啉并螺噁嗪类光致变色化合物及其制备方法 Quinoline and spirooxazine class of photochromic compounds and methods
05/30/2012CN102477047A 取代螺噁嗪类光致变色化合物的制备方法 Replace spirooxazine class photoluminescence preparation of photochromic compound
05/30/2012CN102477046A 取代螺噁嗪类光致变色化合物的制备方法 Replace spirooxazine class photoluminescence preparation of photochromic compound
05/30/2012CN101928291B Method for separating and purifying ansamitocin from precious orange synnema actinomycetes fermentation liquor
05/30/2012CN101633669B Novel method for protecting 31-position or 42-position hydroxyl of rapamycin by selective silicon etherification
05/30/2012CN101429200B Tricyclic benzopyran compound as anti-arrhythmic agents
05/30/2012CN101400657B Polycyclic cinnamide derivative
05/24/2012WO2012066502A1 Processes for preparation of everolimus and intermediates thereof
05/24/2012WO2012066003A1 Compound for the covalent attachment of the chemiluminescent probe n-(4-aminobutyl)-n-ethylisoluminol (abei) to target molecules and uses thereof
05/24/2012US20120129846 Gamma secretase modulators
05/24/2012US20120129833 Cyclic ketoenols for therapy
05/24/2012CA2818389A1 Substituted 4-(selenophen-2(or 3)-ylamino)pyrimidine compounds and methods of use thereof
05/24/2012CA2818225A1 Processes for preparation of everolimus and intermediates thereof
05/23/2012EP2454266A1 9e-15-(2-pyrrolidin-1-yl-ethoxy)-7,12,25-trioxa-19,21,24-triaza- tetracyclo[18.3.1.1(2,5).1(14)18)]hexacosa-1(24),2,4,9,14,16,18(26),20,22-nonaene citrate salt
05/23/2012EP2454265A2 Deuterated 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses
05/23/2012EP2454253A1 Aminopyridine derivatives for treating tumors and inflammatory diseases
05/23/2012EP2454239A1 Substituted triazole and imidazole derivatives as gamma secretase modulators
05/23/2012EP1812448B1 Organic compounds
05/23/2012CN102471349A 构象受限的完全合成的大环化合物 Completely synthetic macrocyclic compounds conformationally constrained
05/23/2012CN102471334A 促代谢型谷氨酸受体调节剂 Metabotropic glutamate receptor modulators
05/23/2012CN102471317A 用于治疗肿瘤和炎性疾病的氨基吡啶衍生物 For the treatment of cancer and inflammatory diseases aminopyridine derivative
05/23/2012CN102471296A Bace抑制剂 Bace Inhibitors
05/23/2012CN102464669A Amorphous everolimus and preparation method thereof
1 ... 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 ... 220